These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 38844975)
21. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis. Lu C; Shan Z; Hong J; Yang L Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966 [TBL] [Abstract][Full Text] [Related]
22. Targeting of SPP1 by microRNA-340 inhibits gastric cancer cell epithelial-mesenchymal transition through inhibition of the PI3K/AKT signaling pathway. Song SZ; Lin S; Liu JN; Zhang MB; Du YT; Zhang DD; Xu WH; Wang HB J Cell Physiol; 2019 Aug; 234(10):18587-18601. PubMed ID: 30953349 [TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA LINP1 functions as an oncogene in endometrial cancer progression by regulating the PI3K/AKT signaling pathway. Zhang XH; Li M; Kang YJ; Xie YQ; Cao YX Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6830-6838. PubMed ID: 31486482 [TBL] [Abstract][Full Text] [Related]
24. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133 [TBL] [Abstract][Full Text] [Related]
25. LINC00665 promotes the viability, migration and invasion of T cell acute lymphoblastic leukemia cells by targeting miR-101 via modulating PI3K/Akt pathway. Abuduer M; A EZG Tissue Cell; 2021 Aug; 71():101579. PubMed ID: 34171521 [TBL] [Abstract][Full Text] [Related]
26. Overexpression of HOXC10 promotes glioblastoma cell progression to a poor prognosis via the PI3K/AKT signalling pathway. Guan Y; He Y; Lv S; Hou X; Li L; Song J J Drug Target; 2019 Jan; 27(1):60-66. PubMed ID: 29768063 [TBL] [Abstract][Full Text] [Related]
27. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway. Yang WB; Zhang WP; Shi JL; Wang JW Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192 [TBL] [Abstract][Full Text] [Related]
28. Knockdown of NCAPD3 inhibits the tumorigenesis of non-small cell lung cancer by regulation of the PI3K/Akt pathway. Yang F; Zheng Y; Luo Q; Zhang S; Yang S; Chen X BMC Cancer; 2024 Apr; 24(1):408. PubMed ID: 38566039 [TBL] [Abstract][Full Text] [Related]
29. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21. Zhu G; Liu X; Li H; Yan Y; Hong X; Lin Z Int J Immunopathol Pharmacol; 2018; 32():2058738418814341. PubMed ID: 30477356 [TBL] [Abstract][Full Text] [Related]
30. Effects of MicroRNA-19b on the Proliferation, Apoptosis, and Migration of Wilms' Tumor Cells Via the PTEN/PI3K/AKT Signaling Pathway. Liu GL; Yang HJ; Liu B; Liu T J Cell Biochem; 2017 Oct; 118(10):3424-3434. PubMed ID: 28322459 [TBL] [Abstract][Full Text] [Related]
31. LncRNA LINC00511 promotes COL1A1-mediated proliferation and metastasis by sponging miR-126-5p/miR-218-5p in lung adenocarcinoma. Wang Y; Mei X; Song W; Wang C; Qiu X BMC Pulm Med; 2022 Jul; 22(1):272. PubMed ID: 35842617 [TBL] [Abstract][Full Text] [Related]
32. HYOU1 promotes cell proliferation, migration, and invasion via the PI3K/AKT/FOXO1 feedback loop in bladder cancer. Wang W; Jiang X; Xia F; Chen X; Li G; Liu L; Xu Q; Zhu M; Chen C Mol Biol Rep; 2023 Jan; 50(1):453-464. PubMed ID: 36348197 [TBL] [Abstract][Full Text] [Related]
33. Circular RNA circ‑ACACA regulates proliferation, migration and glycolysis in non‑small‑cell lung carcinoma via miR‑1183 and PI3K/PKB pathway. Wu W; Xi W; Li H; Yang M; Yao X Int J Mol Med; 2020 Jun; 45(6):1814-1824. PubMed ID: 32236577 [TBL] [Abstract][Full Text] [Related]
34. Splicing Factor PTBP1 Silencing Induces Apoptosis of Human Cervical Cancer Cells via PI3K/AKT Pathway and Autophagy. Liu T; Zhou Y; Chen L; Liu Q; Hu D; Huang R; Ji H; Lin Y; Sun Y Front Biosci (Landmark Ed); 2024 Aug; 29(8):289. PubMed ID: 39206910 [TBL] [Abstract][Full Text] [Related]
35. Down-regulation of miRNA-196b expression inhibits the proliferation, migration and invasiveness of HepG2 cells while promoting their apoptosis via the PI3K/Akt signaling pathway. Xu F; Zhu F; Wang W; Gao W; Chen X; Yu C Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):159-164. PubMed ID: 32538764 [TBL] [Abstract][Full Text] [Related]
36. Fibroblast activation protein-α promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways. Jia J; Martin TA; Ye L; Meng L; Xia N; Jiang WG; Zhang X Int J Mol Med; 2018 Jan; 41(1):275-283. PubMed ID: 29115573 [TBL] [Abstract][Full Text] [Related]
37. High expression of PXDN is associated with poor prognosis and promotes proliferation, invasion as well as migration in ovarian cancer. Zheng YZ; Liang L Ann Diagn Pathol; 2018 Jun; 34():161-165. PubMed ID: 29661721 [TBL] [Abstract][Full Text] [Related]
38. Silencing LncRNA LINC01305 inhibits epithelial mesenchymal transition in lung cancer cells by regulating TNXB-mediated PI3K/Akt signaling pathway. Yan F; Liu SW; Li XY; Li CC; Wu Y J Biol Regul Homeost Agents; 2020; 34(2):499-508. PubMed ID: 32549529 [TBL] [Abstract][Full Text] [Related]
39. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway. Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484 [TBL] [Abstract][Full Text] [Related]
40. Silencing long non-coding RNA ROR improves sensitivity of non-small-cell lung cancer to cisplatin resistance by inhibiting PI3K/Akt/mTOR signaling pathway. Shi H; Pu J; Zhou XL; Ning YY; Bai C Tumour Biol; 2017 May; 39(5):1010428317697568. PubMed ID: 28459375 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]